Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2018 | 02-2018 | 11-2017 | 08-2017 | 05-2017 | |
| Sales | 617 | 604 | 611 | 0 | 617 |
| Cost of Goods | -86 | N/A | N/A | N/A | N/A |
| Gross Profit | 703 | 604 | 611 | N/A | 617 |
| Operating Expenses | 5,151 | 3,715 | 3,343 | 0 | 2,772 |
| Operating Income | -4,534 | -3,111 | -2,732 | N/A | -2,155 |
| Interest Expense | 29 | 22 | 21 | 0 | 20 |
| Other Income | 209 | 217 | 222 | 0 | 210 |
| Pre-tax Income | -4,354 | -2,916 | -2,531 | 0 | -1,965 |
| Net Income Continuous | -4,354 | -2,916 | -2,531 | N/A | -1,965 |
| Net Income | $-4,354 | $-2,916 | $-2,531 | $N/A | $-1,965 |
| EPS Basic Total Ops | -0.30 | -0.20 | -0.18 | N/A | -0.15 |
| EPS Basic Continuous Ops | -0.30 | -0.20 | -0.18 | N/A | -0.15 |
| EPS Diluted Total Ops | -0.30 | -0.20 | -0.18 | N/A | -0.15 |
| EPS Diluted Continuous Ops | -0.30 | -0.20 | -0.18 | N/A | -0.15 |
| EBITDA(a) | $-4,532 | $-3,109 | $-2,730 | $N/A | $-2,153 |